High-dose vitamin B3 shows promise in treating aggressive brain cancer
Researchers at the University of Calgary report that high-dose vitamin B3 helped 82% of patients remain progression-free for six months in a small trial for glioblastoma.
Standard treatment limits success rates
Glioblastoma is an aggressive form of brain cancer that spreads into surrounding tissue. Standard care typically combines surgery, radiation, and chemotherapy to remove as much of the tumor as possible. Complete removal remains extremely difficult because cancer cells infiltrate healthy brain areas.
Vitamin B3 reactivates immune cells
The new approach uses high-dose niacin to revive immune cells that the cancer has suppressed. In the small trial, 82% of patients remained progression-free after six months when receiving this addition to standard therapy. Researchers believe this vitamin helps fight one of the deadliest brain cancers.
Larger studies confirm safety needs
Scientists state that larger studies are still needed to fully confirm the benefit and safety of this treatment. Edward Waldner was a patient who experienced exhaustion and walking difficulties before his diagnosis. His case illustrates the severe symptoms often seen with this type of tumor.
Reported by one outlet
Only one outlet has published this. Nothing here has been checked against a second report, so read it as that outlet's account and follow the link below for the original.
Reported by
1 independent outlet. Headline as published. Links open the original report.